Yahoo Web Search

Search results

    • GSK outpaces Pfizer in RSV vaccine market

      GSK outpaces Pfizer in RSV vaccine market

      BioPharma Dive via Yahoo Finance· 6 months ago

      Dive Brief: GSK said Wednesday that its new Arexvy vaccine for respiratory syncytial virus pulled in 709 million pounds, or about $860 million, in its...